Miles W. McHugh

Controller, RR Donnelley & Sons Co.

Companies

Horizon Therapeutics Public Ltd CoPrincipal Accounting Officer May 8, 2015 to Jan 6, 2022¹
R1 RCM Holdco Inc.Chief Accounting Officer Sep 10, 2012 to Oct 3, 2012²
RR Donnelley & Sons CoChief financial officer Mar 4, 2008 to May 5, 2011³
RR Donnelley & Sons CoController Jun 15, 2006 to Mar 23, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Horizon Therapeutics Public Ltd Co46,635 shares⁵Jan 5, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 5, 2022Shares withheld for tax 8,175 shares at $101.84 of Horizon Therapeutics Public Ltd Co⁵
Jan 5, 2022Exercised options 18,289 shares of Horizon Therapeutics Public Ltd Co⁵
Dec 1, 2021Sold 79,484 shares at $106.62 of Horizon Therapeutics Public Ltd Co⁶
Dec 1, 2021Exercised options 79,484 shares at $22.14 of Horizon Therapeutics Public Ltd Co⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHorizon Therapeutics Public Ltd Co, Principal Accounting Officer
2
SEC EDGARR1 RCM Holdco Inc., Chief Accounting Officer
3
SEC EDGARRR Donnelley & Sons Co, Chief financial officer
4
SEC EDGARRR Donnelley & Sons Co, Controller
5
SEC EDGARHorizon Therapeutics Public Ltd Co shares after the filing of Jan 5, 2022
6
SEC EDGARForm 4 filed Dec 3, 2021